Eiffel Technologies Ltd., Map Pharmaceuticals deal

Map received exclusive worldwide rights to use Supercritical Fluid ( SCF) technology from EIF to develop products for pulmonary delivery of insulin, pulmonary and nasal delivery of steroids and pulmon...